Even in the Age of the Hundred-Year Life, We Still Want to Stay Young
From Bryan Johnson’s pursuit of immortality to research on SRSF1 and aging: can cells become younger while keeping their identity? In Korea, hwangap—the traditional celebration…
From Bryan Johnson’s pursuit of immortality to research on SRSF1 and aging: can cells become younger while keeping their identity? In Korea, hwangap—the traditional celebration…
How light-sensitive proteins let scientists test what neurons do—and why restoring vision is one of the most compelling applications. The 2026 Nobel Prize in Physiology…
New research is beginning to show that genetic variation in drug targets may help explain why GLP-1 medicines produce such different effects—from weight loss to…
Anthropic’s ART discovery offers an early glimpse of what AI-assisted biology may be able to do—and of the experimental quesAnthropic’s ART discovery offers an early…
Updated: September 2026 | Educational & Scientific Overview RNA therapeutics are moving well beyond their early reputation as niche medicines for rare diseases. siRNA vs…
Updated: September 01 2026 | Educational & Scientific Overview AI protein design is taking this a step further, allowing researchers to generate new protein structures…
Updated: August 27. 2026 | Educational & Scientific Overview Drug discovery has traditionally been measured in years, not months. Researchers first have to identify a…
Updated: August 20, 2026 | Educational & Scientific Overview For years, the idea of a cancer vaccine has sounded almost contradictory. However, the latest Phase…
Series Context: This deep-dive is part of our comprehensive series on next-generation metabolic therapeutics. For the high-level strategy map, see our Pillar Article: The Next…
7 Strategies Moving Beyond Today’s GLP-1 Therapies The landscape of Type 2 diabetes drugs is changing rapidly. GLP-1 therapies transformed glucose control and weight management,…